you are viewing a single comment's thread.
This analyst seems to be drinking Walgreens koolaid...in a past life i conversed with street analysts, take with a grain of salt. he probably just finished talking to IR @ WAG. Its favorable for WAG because they have 2 scenarios, 1. walk away and lose 35 to 40% of prescription volume 2.) take lower reimbursements